Entresto market share?

Do you mean one of these? and for what geography/year:
- Market share by sales (global or US) from recent years
- Market share by prescriptions (US or global)
- Market share within the ARNI class (sacubitril/valsartan only has one ARNI on the market)

Quick context:
- Entresto is the only ARNI approved on the market, so its share within the ARNI class is effectively 100%.
- Globally, Entresto is a top-selling heart failure medication, with annual sales typically reported in the high single- to low-double-digit billions of USD range in recent years (roughly around $7–$8B globally in the most recent periods). In the US, it’s one of the leading branded HF therapies.
- The exact market share by geography and metric can vary year to year and by data source (IQVIA, company filings, etc.).

If you tell me the exact metric (sales share vs prescriptions), geography (US/global), and year, I can give a more precise figure or pull the latest available numbers.